ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00884715
Recruitment Status : Terminated (Program was terminated for business reasons)
First Posted : April 21, 2009
Last Update Posted : September 20, 2013
Sponsor:
Information provided by (Responsible Party):
Endo Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2011
  Actual Study Completion Date : December 2011
  Certification/Extension First Submitted : September 9, 2013